Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour location

Kasper, StefanStefanKasperFoch, CarolineCarolineFochEsser, ReginaReginaEsserLamy, Francois-XavierFrancois-XavierLamyZhang, AimarAimarZhangANN-LII CHENGRouyer, MagaliMagaliRouyerBrodowicz, ThomasThomasBrodowiczZielinski, ChristophChristophZielinski2023-05-102023-05-102023-020959-8049https://scholars.lib.ntu.edu.tw/handle/123456789/630966en[SDGs]SDG3Overall survival with cetuximab every-2-weeks versus standard once-weekly administration schedule for first-line treatment of RAS wild-type metastatic colorectal cancer in patients with left- and right-sided primary tumour locationletter10.1016/j.ejca.2022.11.021365634902-s2.0-85144553237WOS:000911083500001https://api.elsevier.com/content/abstract/scopus_id/85144553237